Concepedia

Impact of the 2014 American Academy of Pediatrics Immunoprophylaxis Policy on the Rate, Severity, and Cost of Respiratory Syncytial Virus Hospitalizations among Preterm Infants

Leonard R. Krilov, Jaime Fergie, Mitchell Goldstein, Lance Brannman

American Journal of Perinatology · 2019 · 37 citations · 24 references

DOIFull text

Open access

Abstract

RSVH risk for preterm versus term infants increased after the policy change, confirming previous national analyses. RSVHs after the policy change were more severe, particularly among younger preterm infants.

References

24

The Burden of Respiratory Syncytial Virus Infection in Young Children

Caroline Breese Hall, Geoffrey A. Weinberg, Marika K. Iwane et al. · New England Journal of Medicine · 2009 · 2.2K citations · Full text

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

PEDIATRICS · 1998 · 1.9K citations

, , +17

Methods for Evaluating Changes in Health Care Policy

Justin B. Dimick, Andrew M. Ryan · JAMA · 2014 · 1.1K citations

, , +16

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Michael T. Brady, Carrie L. Byington, H. Dele Davies et al. · PEDIATRICS · 2014 · 769 citations

Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid

Thomas G. Boyce, Beverly G. Mellen, Edward F. Mitchel et al. · The Journal of Pediatrics · 2000 · 688 citations

, , +8